Neuberger Berman Group LLC, a Bloomberg finance expert, has disclosed an opening position in Deliveroo PLC's 0.5p Ordinary Share, with a total of 29,348,161 shares representing a 1.96% stake. The position was acquired through a cash-settled derivative transaction, with the majority of the shares purchased through a swap. The company did not disclose any purchases or sales of shares or stock-settled derivatives.
Neuberger Berman Group LLC, a prominent financial services firm, has disclosed an opening position in Deliveroo PLC's 0.5p Ordinary Share, holding a total of 29,348,161 shares representing a 1.96% stake [1]. The position was acquired through a cash-settled derivative transaction, with the majority of the shares purchased through a swap. The company did not disclose any purchases or sales of shares or stock-settled derivatives.
The disclosure was made in accordance with Rule 8.3 of the Takeover Code, which mandates the reporting of interests in relevant securities representing 1% or more. The disclosure indicates that Neuberger Berman increased its long position in Deliveroo's ordinary shares by 144,277 shares, purchased at a price of £177.40 per unit [1].
This transaction suggests a bullish stance on Deliveroo's future prospects and underscores Neuberger Berman's strategic investment in the global food delivery market. The firm's recent dealings and strategic investments highlight its active role in the financial sector and its ability to navigate complex market dynamics [1].
In a separate development, Doordash and Deliveroo have entered into a new confidentiality agreement, which will govern the terms of disclosure of certain confidential information by Doordash to Deliveroo [2].
References:
[1] Neuberger Berman Group LLC Form 8.3 Disclosure [URL](https://www.marketscreener.com/news/neuberger-berman-group-llc-form-8-3-deliveroo-plc-ce7c5cd2dc8bf02d)
[2] Doordash and Deliveroo Enter Confidentiality Agreement [URL](https://www.nasdaq.com/articles/doordash-enters-new-confidentiality-agreement-deliveroo)
Comments
No comments yet